Assignee
RESPIRA THERAPEUTICS INC
US·12 granted patents·8 pending applications·17 citations·filing 2013–2025
Top patents by PatentIndex Score
20 records- 0193US10912778B2Methods for treatment of pulmonary hypertensionRESPIRA THERAPEUTICS INC·Filed 2017·Granted Feb 9, 2021·10 cites·17 claims
- 0283US12364701B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2024·Granted Jul 22, 2025·0 cites·33 claims
- 0382US2025332171A1Pde5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0479US12263174B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·19 claims
- 0577US11806314B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·0 cites·37 claims
- 0677US11491161B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2021·Granted Nov 8, 2022·0 cites·30 claims
- 0777US10525216B2Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2016·Granted Jan 7, 2020·3 cites·12 claims
- 0874US2025108180A1Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0974US2025195531A1Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1073US11911390B2PDE5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2021·Granted Feb 27, 2024·0 cites·11 claims
- 1173US11491160B2Methods and compositions for treatment of pulmonary hypertension and other lung disordersRESPIRA THERAPEUTICS INC·Filed 2021·Granted Nov 8, 2022·0 cites·20 claims
- 1270US2016317542A1Pde5 inhibitor powder formulations and methods relating theretoRESPIRA THERAPEUTICS INC·Filed 2014·Application pending·0 cites
- 1369US2024398820A1Methods for treatment of pulmonary hypertensionRESPIRA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1466US10463815B2Inhaler to deliver substances for prophylaxis or prevention of disease or injury caused by the inhalation of biological or chemical agentsRESPIRA THERAPEUTICS INC·Filed 2013·Granted Nov 5, 2019·3 cites·10 claims
- 1565US2023001114A1Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1660US10682476B2Powder inhaler, system and methodsRESPIRA THERAPEUTICS INC·Filed 2015·Granted Jun 16, 2020·1 cites·4 claims
- 1759US11471623B2Powder dispersion methods and devicesRESPIRA THERAPEUTICS INC·Filed 2019·Granted Oct 18, 2022·0 cites·20 claims
- 1852US2022296521A1Carrier-based formulations and related methodsRESPIRA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1949US10441733B2Powder dispersion devices and methodsRESPIRA THERAPEUTICS INC·Filed 2013·Granted Oct 15, 2019·0 cites·21 claims
- 2041US2018369513A1Powder dispersion devices and methodsRESPIRA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →